Investment Management
* As early as 7 Mar we advised to Buy the iShares MSCI India ETF (INDA): http://www.bluephoenixfinancials.com/etf-strategies/ishares-msci-india-etf-buy-profit-potential-bjp-win/ * On 13 May INDA traded as high as $28.25, over and above our $28.00 target price * Investors who followed our advice have made a profit of 12.50% in 2 months * We advise Investors to liquidate their […]
* As early as 5 March we advised to Buy USD/JPY: http://www.bluephoenixfinancials.com/foreign-exchange-strategies/usdjpy-buy-uptrend-starting/ * On 21 April we advised to Add to USD/JPY Long Positions: http://www.bluephoenixfinancials.com/foreign-exchange-strategies/usdjpy-add-long-positions-japan-trade-deficit-widens/ * We now advise Investors to hold on to their long positions as we see an upside break coming for USD/JPY * The yen is poised to break out of its narrow price range and […]
* iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund’s objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease * The index is […]
Sign up our newsletter for FREE financial advice and investment tips delivered to your inbox on weekly basis.
Want to keep in touch with news from Blue Phoenix Financials? Subscribe to our RSS feed using by clicking on the button to the right, or subscribe to our newsletter by filling out the form below.